Roche Holding AG
🇨🇭XSWX.ROGSwitzerlandNot reported
PriceCHF 321.70-1.10 (-0.34%)
Latest anomalies
Neutral 0 detected in the last 120 days
- High: 5
- Medium: 2
- Low: 0
Asset turnover: a sudden drop below its trailing quarter average
Days inventory outstanding: a sudden spike above its trailing quarter average
Days payables outstanding: a sudden spike above its trailing quarter average
Fixed asset turnover: a sudden drop below its trailing quarter average
Operating cycle: a sudden spike above its trailing quarter average
Free with a Finzer account.
Profile
- Switzerland
Identity
- Exchange
- SIX Swiss Exchange . XSWX
- Type
- Stock
- ISIN
- CH0012032048
- CUSIP
- Not reported
Company
- Employees
- Not reported
- Headquarters
- Germany
- Website
- Not reported
Market
- Shares outstanding
- 689.6M
- Market cap
- CHF 221.85B
Highlights
- Market cap
- CHF 221.85B
- EPS LTM
- CHF 13.81
- P/E LTM
- 23.30calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 7.35%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- CHF 60.77B-5.62%down year on year
- Net income
- CHF 11.03B-24.76%down year on year
- Gross margin
- 72.64%+5.89%up year on year
- Free cash flow
- CHF 11.69B-32.8%down year on year
Latest news
News is not sourced for this exchange.
Business summary
Roche Holding AG is listed on SIX Swiss Exchange (Switzerland) under the ticker ROG. Its market capitalisation is CHF 221.85B, from 689.6M shares outstanding, as of . Across the 156 trading sessions to the shares traded between CHF 252.70 and CHF 374.90, and the last close of CHF 321.70 sits 56% of the way up that range. The same company also trades as ROG on Cboe Canada - NEO-L (Market by Order), and as RHO on Frankfurt Stock Exchange.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.